Literature DB >> 24917205

Feasibility of esophageal reconstruction using a pedicled jejunum with intrathoracic esophagojejunostomy in the upper mediastinum for esophageal cancer.

Itasu Ninomiya1, Kouichi Okamoto, Katsunobu Oyama, Hironori Hayashi, Tomoharu Miyashita, Hidehiro Tajima, Hirohisa Kitagawa, Sachio Fushida, Takashi Fujimura, Tetsuo Ohta.   

Abstract

OBJECTIVE: An alternative conduit is needed when the gastric tube cannot be used as an esophageal substitute for reconstruction after esophagectomy. We adopted pedicle jejunal reconstruction with intrathoracic anastomosis in the upper mediastinum under such circumstances. The aim of this study was to evaluate the feasibility of this technique.
METHODS: Two hundred and ten patients with esophageal cancer underwent esophagectomy and reconstruction from 1998 to 2013. Among them, 6 patients underwent colon interposition (colon group) and 13 underwent jejunum reconstruction (jejunum group) including 8 thoracoscopic anastomosis. The operative results of both groups were compared with those of 191 gastric tube reconstructions (stomach group).
RESULTS: The operative times in the colon and jejunum groups were significantly longer than that in the stomach group (P = 0.001 and P = 0.018, respectively). The colon group showed more operative blood loss and more frequent anastomotic leakage and ischemic stenosis of the conduit than did the stomach group (1605 vs. 530 g, P = 0.007; 50 vs. 12.6 %, P = 0.035; 16.7 vs. 0 %, P = 0.03, respectively). There was no anastomotic leakage, conduit necrosis and mortality in the jejunum group. Ischemic stenosis of the conduit occurred more frequently in jejunum group than in the stomach group (23.1 vs. 0 %, P < 0.001). However, the stenosis could be managed safely with endoscopic treatment. Patient survival in the colon and jejunum groups was consistent with that in the stomach group.
CONCLUSIONS: Pedicle jejunal reconstruction with intrathoracic anastomosis can be performed safely under thoracotomy or thoracoscopic surgery when stomach cannot be used as an esophageal substitute after esophagectomy.

Entities:  

Mesh:

Year:  2014        PMID: 24917205     DOI: 10.1007/s11748-014-0435-5

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  21 in total

1.  Retrosternal pedicled jejunum interposition: an alternative for reconstruction after total esophago-gastrectomy.

Authors:  Alfred Maier; H Pinter; F Tomaselli; O Sankin; S Gabor; B Ratzenhofer-Komenda; F M Smolle-Jüttner
Journal:  Eur J Cardiothorac Surg       Date:  2002-11       Impact factor: 4.191

2.  The surgical treatment of carcinoma of the oesophagus; with special reference to a new operation for growths of the middle third.

Authors:  I LEWIS
Journal:  Br J Surg       Date:  1946-07       Impact factor: 6.939

3.  Minimally invasive intrathoracic esophagogastric anastomosis: circular stapler technique with transoral placement of the anvil.

Authors:  Ninh T Nguyen; Xuan-Mai T Nguyen; Hossein Masoomi
Journal:  Semin Thorac Cardiovasc Surg       Date:  2010

4.  A New Method for Constructing an Artificial Esophagus.

Authors:  W P Longmire; M M Ravitch
Journal:  Ann Surg       Date:  1946-05       Impact factor: 12.969

5.  Anterothoracic Oesophagoplasty for Impermeable Stricture of the Oesophagus.

Authors:  A Ochsner; N Owens
Journal:  Ann Surg       Date:  1934-12       Impact factor: 12.969

Review 6.  Thrombotic microangiopathy with targeted cancer agents.

Authors:  John A Blake-Haskins; Robert J Lechleider; Robert J Kreitman
Journal:  Clin Cancer Res       Date:  2011-08-03       Impact factor: 12.531

7.  Clinical outcome of esophageal cancer patients with history of gastrectomy.

Authors:  Hiroshi Wada; Yuichiro Doki; Kiyonori Nishioka; Osamu Ishikawa; Toshiyuki Kabuto; Masahiko Yano; Morito Monden; Shingi Imaoka
Journal:  J Surg Oncol       Date:  2005-02-01       Impact factor: 3.454

8.  Supercharged pedicled jejunal interposition for esophageal replacement: a 10-year experience.

Authors:  Shanda H Blackmon; Arlene M Correa; Roman Skoracki; Pierre M Chevray; Min P Kim; Reza J Mehran; David C Rice; Jack A Roth; Stephen G Swisher; Ara A Vaporciyan; Peirong Yu; Garrett L Walsh; Wayne L Hofstetter
Journal:  Ann Thorac Surg       Date:  2012-08-29       Impact factor: 4.330

9.  Results of video-assisted thoracoscopic surgery for esophageal cancer during the induction period.

Authors:  Itasu Ninomiya; Harushi Osugi; Takashi Fujimura; Masato Kayahara; Hiroyuki Takamura; Masashi Takemura; Shigeru Lee; Hisatoshi Nakagawara; Genichi Nishimura; Tetsuo Ohta
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-03-14

10.  Esophageal replacement by colon interposition.

Authors:  R J Cerfolio; M S Allen; C Deschamps; V F Trastek; P C Pairolero
Journal:  Ann Thorac Surg       Date:  1995-06       Impact factor: 4.330

View more
  5 in total

1.  Alternative conduits for esophageal replacement.

Authors:  Ankur Bakshi; David J Sugarbaker; Bryan M Burt
Journal:  Ann Cardiothorac Surg       Date:  2017-03

2.  Gastric tube reconstruction prevents postoperative recurrence and metastasis of esophageal cancer.

Authors:  Runqi Zhang; Peng Wang; Xiaoyan Zhang; Lei Zhang; Chao Li
Journal:  Oncol Lett       Date:  2016-02-17       Impact factor: 2.967

Review 3.  European perspective in Thoracic surgery-eso-coloplasty: when and how?

Authors:  Lucile Gust; Moussa Ouattara; Willy Coosemans; Philippe Nafteux; Pascal Alexandre Thomas; Xavier Benoit D'Journo
Journal:  J Thorac Dis       Date:  2016-04       Impact factor: 2.895

Review 4.  Reconstruction after esophagectomy for esophageal cancer patients with a history of gastrectomy.

Authors:  Masayuki Watanabe; Shinji Mine; Koujiro Nishida; Takanori Kurogochi; Akihiko Okamura; Yu Imamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-05-27

5.  Comparison of outcomes of pedicled jejunal and colonic conduit for esophageal reconstruction.

Authors:  Sicong Jiang; Changying Guo; Bin Zou; Jianguo Xie; Zhihui Xiong; Yukang Kuang; Jianjun Tang
Journal:  BMC Surg       Date:  2020-07-16       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.